INVO Fertility, Inc. IVF
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -34.32% | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -34.32% | -- | -- | -- | -- |
| Cost of Revenue | -28.16% | -- | -- | -- | -- |
| Gross Profit | -43.25% | -- | -- | -- | -- |
| SG&A Expenses | -29.42% | -- | -- | -- | -- |
| Depreciation & Amortization | -63.88% | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -32.77% | -- | -- | -- | -- |
| Operating Income | 30.70% | -- | -- | -- | -- |
| Income Before Tax | -268.11% | -- | -- | -- | -- |
| Income Tax Expenses | -1,571.88% | -- | -- | -- | -- |
| Earnings from Continuing Operations | -260.11% | -- | -- | -- | -- |
| Earnings from Discontinued Operations | 100.00% | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 72.83% | -- | -- | -- | -- |
| EBIT | 30.70% | -- | -- | -- | -- |
| EBITDA | 30.21% | -- | -- | -- | -- |
| EPS Basic | 98.90% | -- | -- | -- | -- |
| Normalized Basic EPS | -- | -- | -- | -- | -- |
| EPS Diluted | 98.89% | -- | -- | -- | -- |
| Normalized Diluted EPS | -- | -- | -- | -- | -- |
| Average Basic Shares Outstanding | -- | -- | -- | -- | -- |
| Average Diluted Shares Outstanding | 20,063.36% | -- | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |